Search Results for "New Treatment For Hepatitis B"

20:16 EDT 28th May 2015 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis B?related PAN

Hepatitis B virus HBV

Matching News

Genes show the way to better treatment of hepatitis A

One of the most common causes of hepatitis A (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not all patients are cure...

Genes show the way to better treatment of hepatitis C

(Aarhus University) One of the most common causes of hepatitis C (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not a...

AbbVie's Hepatitis C Treatment Gains FDA Approval

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.The Food and Drug Administration on Friday a...

Hepatitis C and HIV Co-infection Closing the Gaps

Hepatitis C virus (HCV) infection causes substantial morbidity and mortality, but patients with human immunodeficiency virus (HIV) co-infection are 3 times more likely to develop cirrhosis or liver de...

Worldwide Treatment of Hepatitis C: Within Sight At Right Cost?

Lowering the cost of hepatitis C drugs is possible and key to achieving global access to treatment, according to new research by the University of Liverpool and Imperial College London.   Read more ...

Achillion Pharma Reports 6-week Treatment Cure In Hepatitis C Using Combo Drug Mix

Shares of Achillion Pharmaceuticals (ACHN) gained about 7% in today’s market session after the company reported that combining its Hepatitis C treatment ACH-3102 together with Gilead Sciences (G...

Advances in hepatitis C treatment. Why aren’t they being used?

The really incredible advances in the treatment of hepatitis C bring to life several relevant questions as we move forward into 2015. First, who should be treating hepatitis C patients (primary care p...

NICE recommends Harvoni for hepatitis C

NICE has signalled a provisional OK for Gilead’s Harvoni to be used as a treatment for hepatitis C by the NHS. In draft guidance the healthcare watchdog approved Harvoni (ledipasvir-sofosbuvir) as a...

Matching PubMed Articles

New foe treated with old guns ¿ supportive role of steroids in the treatment of acute severe hepatitis E.

BackgroundAutochthonous hepatitis E has been observed with growing incidence in industrialized countries. Hepatitis E virus infection causes an acute hepatitis with spontaneous resolution in the major...

Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy.

Although hepatitis is frequently observed during antituberculosis (anti-TB) therapy, acute viral hepatitis should be ruled out first, especially in the endemic areas. In addition to common types of vi...

Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis.

A wide variety of competing drugs are available to patients for the treatment of chronic hepatitis B. We update a recent meta-analysis to include additional trial evidence with the aim of determining ...

Personalized treatment of hepatitis B.

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individu...

Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B.

Chronic hepatitis B is one of the leading causes of cirrhosis and hepatocellular carcinoma globally. At present, seven drugs, including two interferons and five oral nucleos(t)ide analogues (NAs), hav...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement